Furthermore, CXCR4 has been identified as a prognostic marker for various types of cancer, including leukaemia, breast cancer and prostate cancer (Khare et al., 2021; Yu et al., 2023; Bao et al., 2023). Here, CXCR4 is linked to breast cancer.